Free Trial

Sensus Healthcare (SRTS) Competitors

Sensus Healthcare logo
$4.64 -0.10 (-2.11%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$4.68 +0.04 (+0.75%)
As of 04:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SRTS vs. CATX, NNOX, SNWV, NYXH, ZIMV, SMTI, TCMD, STIM, NVRO, and TLSI

Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), Sanuwave Health (SNWV), Nyxoah (NYXH), ZimVie (ZIMV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), Neuronetics (STIM), Nevro (NVRO), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

Sensus Healthcare vs. Its Competitors

Sensus Healthcare (NASDAQ:SRTS) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Sensus Healthcare has higher revenue and earnings than Perspective Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensus Healthcare$41.81M1.82$6.65M$0.1046.40
Perspective TherapeuticsN/AN/A-$46.51MN/AN/A

In the previous week, Sensus Healthcare had 1 more articles in the media than Perspective Therapeutics. MarketBeat recorded 3 mentions for Sensus Healthcare and 2 mentions for Perspective Therapeutics. Perspective Therapeutics' average media sentiment score of 0.80 beat Sensus Healthcare's score of 0.72 indicating that Perspective Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sensus Healthcare
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Perspective Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sensus Healthcare has a net margin of 4.56% compared to Perspective Therapeutics' net margin of -4,096.66%. Sensus Healthcare's return on equity of 3.34% beat Perspective Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Sensus Healthcare4.56% 3.34% 3.00%
Perspective Therapeutics -4,096.66%-27.40%-23.16%

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by company insiders. Comparatively, 3.7% of Perspective Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sensus Healthcare has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500.

Sensus Healthcare presently has a consensus target price of $11.67, indicating a potential upside of 151.44%. Perspective Therapeutics has a consensus target price of $12.56, indicating a potential upside of 282.79%. Given Perspective Therapeutics' higher possible upside, analysts plainly believe Perspective Therapeutics is more favorable than Sensus Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Perspective Therapeutics
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
3 Strong Buy rating(s)
3.18

Summary

Sensus Healthcare beats Perspective Therapeutics on 9 of the 14 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTS vs. The Competition

MetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$77.95M$6.78B$5.48B$8.94B
Dividend YieldN/A1.04%5.38%4.12%
P/E Ratio46.4027.0626.2219.74
Price / Sales1.8285.89394.92109.12
Price / Cash10.9721.0536.4957.06
Price / Book1.364.707.915.37
Net Income$6.65M$173.18M$3.15B$248.34M
7 Day Performance-3.33%0.20%0.75%1.67%
1 Month Performance-1.69%-1.11%3.46%4.56%
1 Year Performance-5.88%24.36%34.60%18.42%

Sensus Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTS
Sensus Healthcare
2.0441 of 5 stars
$4.64
-2.1%
$11.67
+151.4%
-6.9%$77.95M$41.81M46.4040
CATX
Perspective Therapeutics
1.6986 of 5 stars
$4.11
+18.8%
$12.56
+205.5%
-70.7%$305.08M$1.43M0.0070
NNOX
Nano-X Imaging
1.8868 of 5 stars
$4.95
-0.8%
$9.50
+91.9%
-28.5%$288.32M$11.28M-5.50190News Coverage
SNWV
Sanuwave Health
N/A$33.57
-0.3%
N/AN/A$288.15M$32.63M-7.3740Positive News
NYXH
Nyxoah
3.212 of 5 stars
$7.83
+1.6%
$14.50
+85.2%
+7.4%$262.61M$4.89M-3.68110
ZIMV
ZimVie
2.5011 of 5 stars
$8.65
-1.6%
$16.33
+88.8%
-45.7%$244.78M$449.75M-12.181,770
SMTI
Sanara MedTech
2.2222 of 5 stars
$27.82
+2.0%
$49.50
+77.9%
+6.9%$242.46M$86.67M-20.7660Positive News
TCMD
Tactile Systems Technology
3.6039 of 5 stars
$10.17
+2.0%
$16.00
+57.3%
-10.3%$231.79M$292.98M15.411,037Positive News
STIM
Neuronetics
2.535 of 5 stars
$3.43
-0.9%
$5.50
+60.3%
+97.7%$227.74M$74.89M-2.62180
NVRO
Nevro
0.1695 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-32.1%$224.32M$408.52M-3.091,090
TLSI
TriSalus Life Sciences
2.985 of 5 stars
$5.29
-5.4%
$10.75
+103.2%
-3.4%$211.52M$29.43M-4.72106Gap Down

Related Companies and Tools


This page (NASDAQ:SRTS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners